EP1827494A4 - Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes - Google Patents

Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes

Info

Publication number
EP1827494A4
EP1827494A4 EP05823219A EP05823219A EP1827494A4 EP 1827494 A4 EP1827494 A4 EP 1827494A4 EP 05823219 A EP05823219 A EP 05823219A EP 05823219 A EP05823219 A EP 05823219A EP 1827494 A4 EP1827494 A4 EP 1827494A4
Authority
EP
European Patent Office
Prior art keywords
therapy
organs
acute
treatment
chronic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05823219A
Other languages
German (de)
English (en)
Other versions
EP1827494A2 (fr
Inventor
Wayne Franco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/991,592 external-priority patent/US7166280B2/en
Priority claimed from US11/114,851 external-priority patent/US20050277576A1/en
Priority claimed from US11/179,245 external-priority patent/US20070111935A1/en
Application filed by Individual filed Critical Individual
Publication of EP1827494A2 publication Critical patent/EP1827494A2/fr
Publication of EP1827494A4 publication Critical patent/EP1827494A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05823219A 2004-11-18 2005-11-17 Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes Withdrawn EP1827494A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/991,592 US7166280B2 (en) 2000-04-06 2004-11-18 Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
US11/114,851 US20050277576A1 (en) 2000-04-06 2005-04-26 Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US11/179,245 US20070111935A1 (en) 2000-04-06 2005-07-12 Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
PCT/US2005/041740 WO2006055743A2 (fr) 2004-11-18 2005-11-17 Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes

Publications (2)

Publication Number Publication Date
EP1827494A2 EP1827494A2 (fr) 2007-09-05
EP1827494A4 true EP1827494A4 (fr) 2010-02-17

Family

ID=36407758

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05823219A Withdrawn EP1827494A4 (fr) 2004-11-18 2005-11-17 Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes

Country Status (2)

Country Link
EP (1) EP1827494A4 (fr)
WO (1) WO2006055743A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105062962B (zh) * 2015-09-15 2018-09-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞生物制剂及其制备方法和应用
WO2018182612A1 (fr) * 2017-03-30 2018-10-04 Progenity Inc. Procédés et dispositifs pouvant être ingérés pour la libération régio-spécifique de cellules souches au site d'une maladie du tractus gastro-intestinal

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049300A2 (fr) * 1997-04-25 1998-11-05 Collateral Therapeutics Formes tronquees de proteines apparentees au facteur vegf
WO2001094420A1 (fr) * 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification et utilisation des cellules progenitrices endotheliales derivees de la moelle osseuse, destinees a ameliorer la fonction du myocarde apres un accident ischemique
US20020058612A1 (en) * 2000-04-06 2002-05-16 Franco Wayne P. Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
WO2002064157A2 (fr) * 2001-01-23 2002-08-22 Boston Scientific Corporation Procede d'injection myocardiale localisee dans le traitement du myocarde ischemique
WO2003024478A1 (fr) * 2001-09-19 2003-03-27 Neuronova Ab Traitement des troubles du systeme nerveux central
WO2004009767A2 (fr) * 2002-07-23 2004-01-29 Boston Scientific Limited Therapie cellulaire de regeneration
US20040048375A1 (en) * 2001-09-30 2004-03-11 Scicotec Gmbh Application of pluripotential stem cells for body organ tissue repair and venous capillary expansion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US20020051762A1 (en) * 1998-01-23 2002-05-02 Shahin Rafii Purified populations of endothelial progenitor cells

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049300A2 (fr) * 1997-04-25 1998-11-05 Collateral Therapeutics Formes tronquees de proteines apparentees au facteur vegf
US20020058612A1 (en) * 2000-04-06 2002-05-16 Franco Wayne P. Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
WO2001094420A1 (fr) * 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification et utilisation des cellules progenitrices endotheliales derivees de la moelle osseuse, destinees a ameliorer la fonction du myocarde apres un accident ischemique
WO2002064157A2 (fr) * 2001-01-23 2002-08-22 Boston Scientific Corporation Procede d'injection myocardiale localisee dans le traitement du myocarde ischemique
WO2003024478A1 (fr) * 2001-09-19 2003-03-27 Neuronova Ab Traitement des troubles du systeme nerveux central
US20040048375A1 (en) * 2001-09-30 2004-03-11 Scicotec Gmbh Application of pluripotential stem cells for body organ tissue repair and venous capillary expansion
WO2004009767A2 (fr) * 2002-07-23 2004-01-29 Boston Scientific Limited Therapie cellulaire de regeneration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MALECKI M ET AL: "VEGF165 AND FGF-2 for angiogenic gene therapy: a bicistronic strategy", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, vol. 11, no. Suppl. 1, 1 February 2004 (2004-02-01), pages S165 - S166, XP009125239, ISSN: 0969-7128 *
YLA-HERTTUALA SEPPO ET AL: "Gene transfer as a tool to induce therapeutic vascular growth.", NATURE MEDICINE, vol. 9, no. 6, June 2003 (2003-06-01), pages 694 - 701, XP002561932, ISSN: 1078-8956 *

Also Published As

Publication number Publication date
EP1827494A2 (fr) 2007-09-05
WO2006055743A3 (fr) 2008-07-17
WO2006055743A2 (fr) 2006-05-26

Similar Documents

Publication Publication Date Title
HRP20150175T1 (en) Means and methods for the treatment of tumorous diseases
EP1968607A4 (fr) Traitement du cancer et d'autres maladies
EP1814909A4 (fr) Utilisation de aimp2dx2 pour diagnostiquer et traiter un cancer
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL181305A0 (en) Combinations for the treatment of diseases involving cell proliferation
EP1732462A4 (fr) Traitement electromagnetique de tissus et de cellules
EP1811844A4 (fr) Méthodes de diagnostic et de traitement du cancer
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
IL180992A0 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
EP1841462A4 (fr) Mobilisation par therapie au facteur de croissance de cellules souches dans le sang peripherique
IL178827A0 (en) Use of reboxetine for the treatment of pain
EP1838260A4 (fr) Systeme et procede destines au traitement du tissu cardiaque
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
EP1773882A4 (fr) Diagnostic et traitement de maladies associees a siglec-6
TWI347843B (en) Treatment of bacterial diseases of the respiratory organs
ZA200709542B (en) Combination therapy in the treatment of cancer
EP1827494A4 (fr) Combinaison de therapie au facteur de croissance et de therapie cellulaire pour le traitement de maladies aigues et chroniques des organes
GB0425854D0 (en) Therapeutic treatment
EP1807108A4 (fr) Techniques de traitement et de prevention de maladies de conduits biologiques
ZA200802541B (en) Human antibodies against IL13 and therapeutic uses
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0406709D0 (en) Physical treatment of tumour and tissue
GB0408752D0 (en) Therapeutic treatment
GB0411934D0 (en) Physical treatment of tumour or tissue

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070618

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20080717

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/18 20060101AFI20080801BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100120

17Q First examination report despatched

Effective date: 20100512

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110621